A detailed history of Forsta Ap Fonden transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Forsta Ap Fonden holds 548,400 shares of BMY stock, worth $22.2 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
548,400
Previous 518,800 5.71%
Holding current value
$22.2 Million
Previous $26.6 Million 11.72%
% of portfolio
0.26%
Previous 0.27%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$47.98 - $54.4 $1.42 Million - $1.61 Million
29,600 Added 5.71%
548,400 $29.7 Million
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $2.72 Million - $3.25 Million
-56,100 Reduced 9.76%
518,800 $26.6 Million
Q3 2023

Oct 25, 2023

SELL
$57.89 - $64.73 $185,248 - $207,136
-3,200 Reduced 0.55%
574,900 $33.4 Million
Q2 2023

Aug 03, 2023

SELL
$63.71 - $70.74 $1.59 Million - $1.76 Million
-24,900 Reduced 4.13%
578,100 $37 Million
Q1 2023

Apr 21, 2023

SELL
$65.71 - $74.53 $3.35 Million - $3.8 Million
-51,000 Reduced 7.8%
603,000 $41.8 Million
Q4 2022

Feb 02, 2023

BUY
$68.48 - $81.09 $6.18 Million - $7.32 Million
90,300 Added 16.02%
654,000 $47 Million
Q3 2022

Oct 17, 2022

BUY
$0.13 - $76.84 $9,672 - $5.72 Million
74,400 Added 15.21%
563,700 $40.1 Million
Q2 2022

Aug 11, 2022

SELL
$72.62 - $79.98 $733,462 - $807,798
-10,100 Reduced 2.02%
489,300 $37.7 Million
Q1 2022

May 09, 2022

SELL
$61.48 - $73.72 $2.01 Million - $2.41 Million
-32,700 Reduced 6.15%
499,400 $36.5 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $997,518 - $1.16 Million
-18,600 Reduced 3.38%
532,100 $33.2 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $3.31 Million - $3.87 Million
55,900 Added 11.3%
550,700 $32.6 Million
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $3.03 Million - $3.3 Million
48,900 Added 10.97%
494,800 $33.1 Million
Q1 2021

May 11, 2021

SELL
$59.34 - $66.74 $4.05 Million - $4.55 Million
-68,200 Reduced 13.27%
445,900 $28.2 Million
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $4.9 Million - $5.55 Million
84,800 Added 19.75%
514,100 $31.9 Million
Q3 2020

Oct 22, 2020

BUY
$57.43 - $63.64 $838,478 - $929,144
14,600 Added 3.52%
429,300 $25.9 Million
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $3.96 Million - $4.63 Million
72,300 Added 21.12%
414,700 $24.4 Million
Q1 2020

May 04, 2020

BUY
$46.4 - $67.43 $15.9 Million - $23.1 Million
342,400 New
342,400 $19.1 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Forsta Ap Fonden Portfolio

Follow Forsta Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.